The team

Executive team

Ali Salanti, CEO

Ali Salanti (AS) is founder and CEO of VAR2 Pharmaceuticals. He holds a Ph.D. in medicine and is Professor at University of Copenhagen. AS has a strong background in molecular biology and translational medicine, and he is currently running a clinical development program for a malaria vaccine. He received a ERC consolidator grant in 2014.

Andreas Norlin, COO

Andreas Norlin brings extensive experience of strategic planning and execution of complex development projects from >17 years in the biotechnology and pharma industry. Andreas has a Ph.D. in Animal Physiology and M.Sc. in Biology from Lund University, Lund, Sweden.

Mads Daugaard, Executive 
chairman of the board

Mads Daugaard (MD) is founder of VAR2 Pharmaceuticals, and CSO of Vancouver branch. He is Principal Investigator at the University of British Columbia, Centre of Excellence in Translational Oncology, the Vancouver Prostate Centre (VPC). MD has a strong background in translational cancer biology, molecular biology and biochemistry. He has more than 10 years of experience working on molecular aspects of cancer biology.